Tests for glioma based on the determining concentrations of HIF-1α, ANG-2, and IL-1β will indicate the presence of the disease at higher concentrations of these proteins, because the diagnostic value of each variable increases with concentration. The gene discussed is ANGPT2; the disease is central nervous system cancer.